<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        126-9-16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VOLTAREN 50 MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="NOVARTIS Saglik Gida ve Tarm" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            NOVARTIS Saglik Gida ve Tarm
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Voltaren is: </strong></p><p>The active substance in Voltaren gastro-resistant tablets (GR tablets) is diclofenac sodium.</p><p>Voltaren belongs to a group of medicines called &ldquo;non-steroidal anti-inflammatory drugs&rdquo; (NSAIDs), which are used to treat pain and inflammation.</p><p><strong>What Volatren is used for</strong></p><p><strong><u>GR tablets</u></strong> can be used to treat the following conditions:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rheumatic or degenerative joint pain (arthritis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Back pain, frozen shoulder, tennis elbow, and other types of rheumatism.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gout attacks.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sprains, strains and other injuries.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain and swelling after surgery.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Painful inflammatory conditions in gynecology, including menstrual periods.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infections of the ear, nose and throat.</p><p>How Voltaren works:</p><p>Voltaren relieves the symptoms of inflammation, such as pain and swelling, by blocking the synthesis of the molecules (prostaglandins) responsible for inflammation, pain and fever. It has no effect on the causes of inflammation or fever.</p><p>If you have any questions about how Voltaren works or why this medicine has been prescribed to you, ask your doctor.</p><p>Monitoring during your treatment with Voltaren</p><p>If you have&nbsp; mild congestive heart failure (NYHA-I) or significant risks for heart disease, your doctor will periodically re-evaluate whether you should continue treatment with Voltaren, especially in case you are treated for more than 4 weeks.</p><p>If you have any liver impairment, kidney impairment or blood impairment, you will have blood tests during treatment. These will monitor either your liver function (level of transaminases) or your kidney function (level of creatinine) or your blood count (level of white and red blood cells and platelets). Your doctor will take these blood tests into consideration to decide if Voltaren needs to be discontinued or if the dose needs to be changed</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow all the doctor&rsquo;s instructions carefully. They may differ from the general information contained in this leaflet</p><p><strong>a. Do not take VOLTAREN<sup>&reg;</sup> </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you are</strong> <strong>allergic</strong> (hypersensitive) to diclofenac or to any of the other ingredients of Voltaren listed at the end of this leaflet.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you have</strong> ever had an allergic reaction after taking medicines to treat inflammation or pain (e.g. acetylsalicylic acid, diclofenac or ibuprofen. Reactions may include asthma, runny nose, skin rash, face swelling. If you think you may be allergic, ask your doctor for advice.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you have</strong> a stomach or intestinal ulcer.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you have</strong> gastrointestinal bleeding or perforation, symptoms of which may include blood in your stools or black stools.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you suffer</strong> from kidney or liver failure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you suffer</strong> from established heart disease and/or cerebrovascular disease e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you have</strong> or have had problems with your blood circulation (peripheral arterial disease)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you are</strong> in the last three months of pregnancy.</p><p>If any of these apply to you, <strong>tell your doctor without taking Voltaren</strong>.</p><p>If you think you may be allergic, ask your doctor for advice</p><p><strong>b. Take special care with VOLTAREN<sup>&reg;</sup> </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have mild congestive heart failure (NYHA-I) or significant risk factors such as high blood pressure, abnormally high levels of fat (cholesterol, triglycerides) in your blood, diabetes, or if you smoke, and your doctor decides to prescribe Voltaren, you must not increase the dose above 100 mg per day if you are treated for more than 4 weeks.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is generally important to take the lowest dose of Voltaren that relieves your pain and/or swelling and for the shortest time possible in order to keep your risk for side effects as small as possible.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are taking Voltaren simultaneously with other anti-inflammatory medicines including acetylsalicylic acid, corticosteroids, &ldquo;blood thinners&rdquo; or &ldquo;SSRIs&rdquo; (see &ldquo;Taking other medicines&rdquo;).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have asthma or hay fever (seasonal allergic rhinitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever had gastrointestinal problems such as stomach ulcer, bleeding or black stools, or have experienced stomach discomfort or heartburn after taking anti-inflammatory medicines in the past.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have an inflammation of the colon (ulcerative colitis) or intestinal tract (Crohn&rsquo;s disease).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have liver or kidney problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you could be dehydrated (e.g. by sickness, diarrhea, before or after major surgery).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have swollen feet.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a bleeding disorder or other blood disorders, including a rare liver condition called porphyria.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you recently had or you are going to have a surgery of the stomach or intestinal tract.</p><p>If any of these above apply to you, <strong>tell your doctor before you take GR tablets.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If, at any time while taking Voltaren you experience any signs or symptoms of problems with your heart or blood vessels such as chest pain, shortness of breath, weakness, or slurring of speech, contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Voltaren may reduce the symptoms of an infection (e.g. headache, high temperature) and may therefore make the infection more difficult to detect and to treat adequately. If you feel unwell and need to see a doctor, remember to mention that you are taking Voltaren.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In very rare cases, patients treated with Voltaren, as with other anti-inflammatory medicines, may experience<strong> </strong>severe allergic skin reactions (e.g. rash).</p><p>If you get any of the above described symptoms, <strong>tell your doctor straight away</strong>.</p><p><strong>c. Taking other medicines, herbal or dietary supplements </strong></p><p>It is particularly important to tell your doctor if you are taking any of the following medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lithium or selective serotonin-reuptake inhibitors (SSRIs) (medicines used to treat some types of depression).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin (a medicine used for heart problems).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diuretics (medicines used to increase the amount of urine).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ACE inhibitors or beta-blockers (classes of medicines used to treat high blood pressure and heart failure).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other anti-inflammatory medicines such as acetylsalicylic acid or ibuprofen.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids (medicines used to provide relief for inflamed areas of the body).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ldquo;Blood thinners&rdquo; (medicines used to prevent blood-clotting).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines (such as metformin) used to treat diabetes, except insulin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methotrexate (a medicine used to treat some kinds of cancer or arthritis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciclosporin, Tacrolimus (medicines primarily used in patients who have received organ transplants).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trimethoprim (a medicine used to prevent or treat urinary tract infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quinolone antibacterials (medicines used against infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Voriconazole (a medicine used to treat fungal infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenytoin (a medicine used to treat seizures).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rifampicin (an antibiotic medicine used to treat bacterial infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tell your doctor or a pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p><strong>d. Taking VOLTAREN&reg; with food and drink </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Voltaren GR tablets should be swallowed whole with a glass of water or other liquid.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is recommended to take Voltaren GR tablets before meals or on an empty stomach.</p><p>&nbsp;Older people</p><p>Elderly patients, especially those who are frail or with a low body weight, may be more sensitive to the effects of Voltaren than other adults. They should follow the doctor&rsquo;s instructions particularly carefully and take the lowest dose for their condition. It is especially important for elderly patients to report undesirable effects promptly to their doctor.</p><p>&nbsp;Children and adolescents</p><p>Because of their strength, Voltaren 50 mg GR tablets must not be given to children and adolescents below 14 years of age. For example, Voltaren 25 mg GR tablets could be used for patients below 14 years of age. Voltaren GR tablets must not be given to children under 12 months of age.</p><p><strong>e. Pregnancy and breast-feeding <em>&nbsp;</em></strong></p><p>You should tell your doctor if you are pregnant or think that you may be pregnant, you should not take Voltaren GR tablets, while pregnant unless absolutely necessary.</p><p>As with other anti-inflammatory medicines, you must not take Voltaren GR tablets during the last 3 months of pregnancy, as it could harm your unborn child and cause problems at delivery.</p><p>You should tell your doctor if you are breast-feeding.</p><p>You should not breast-feed if you are taking Voltaren, as it might be harmful for your infant.</p><p>Your doctor will discuss with you the potential risk of taking Voltaren during pregnancy or breast-feeding.</p><p>i. Women of child-bearing potential</p><p>Voltaren may make it more difficult to become pregnant. You should not take Voltaren GR tablets unless necessary if you are planning to become pregnant or if you have problems to become pregnant.</p><p>&nbsp;</p><p><strong>f. Driving and using machines</strong></p><p>If you experience any vision disorders or feel dizzy or drowsy while taking Voltaren, you should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow your doctor&rsquo;s instructions carefully. Do not exceed the recommended dose.</p><p>How much Voltaren to take</p><p>Do not exceed the recommended dose prescribed by your doctor. It is important that you use the lowest dose that controls your pain and that you do not take Voltaren GR tablets for longer than necessary.</p><p>Your doctor will tell you exactly how many GR tablets of Voltaren you should take. Depending on how you respond to the treatment, your doctor may suggest a higher or lower dose.</p><p>Adults</p><p>At the beginning of treatment the daily dose is generally 100 to 150 mg. In milder cases, and for long-term treatment, 75 to 100 mg daily is usually sufficient. The daily dose should usually be divided into 2 to 3 separate doses. Do not exceed 150 mg per day. In painful menstrual periods, start treatment with a dose of 50 to 100 mg as soon as you feel the first symptoms. Continue with 50 mg up to three times a day for a few days, as needed. If the daily dose of 150 mg does not provide sufficient pain relief over 2 to 3 menstrual periods, your doctor may recommend you to take up to 200 mg daily during your next menstrual periods. Do not exceed 200 mg per day.</p><p>Children and adolescents</p><p>Children aged 1 year or over and adolescents should be given 0.5 to 2 mg per kilogram of body weight daily, divided into 2 to 3 separate doses, depending on the severity of the disorder.</p><p>Do not exceed 150 mg per day.</p><p>Example: A child weighing 20 kilograms would thus be given a daily dose of 10 to 40 mg. For treatment of juvenile rheumatoid arthritis, the daily dose can be raised up to a maximum of 3 mg per kilogram of body weight, divided into separate doses.</p><p>When to take Voltaren</p><p>It is recommended to take Voltaren GR tablets before meals or on an empty stomach.</p><p>How to take Voltaren</p><p>Voltaren GR tablets should be swallowed whole with a glass of water or other liquid.</p><p>It is recommended to take Voltaren GR tablets before meals or on an empty stomach. Do not divide or chew the tablets.</p><p>&nbsp;</p><p>How long to take Voltaren</p><p>Follow your doctor&rsquo;s instructions exactly.</p><p>If you take Voltaren for more than a few weeks, you should make sure to visit your doctor for regular check-ups, to ensure that you are not suffering from unnoticed undesirable effects.</p><p>If you have questions about how long to take Voltaren, talk to your doctor or your pharmacist.</p><p><strong>a. If you take more VOLTAREN&reg; than you should </strong></p><p>If you have accidentally taken too much Voltaren<strong>, tell your doctor or pharmacist or go to the hospital emergency unit at once.</strong></p><p>You may require medical attention.</p><p><strong>&nbsp;</strong></p><p><strong>b. If you forget to take VOLTAREN<sup>&reg;</sup> </strong></p><p>If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, you should simply take the next tablet at the usual time. Do not double the next dose to make up for the one you missed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>As with all medicines, patients taking<strong> </strong>Voltaren can experience side effects, although not everybody gets them.</p><p>Some side effects could be serious</p><p><em>These uncommon side effects may affect between 1 and 10 in every 1000 patients, especially when taking a high daily dose (150 mg) for a long period of time</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden and oppressive chest pain (signs of myocardial infarction or heart attack).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Breathlessness, difficulty of breathing when lying down, swelling of the feet or legs (signs of cardiac failure).</p><p><em>These rare or very rare side effects may affect from</em><em> less than 1 to 10 in every 10,000 patients</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Spontaneous bleeding or bruising (signs of thrombocytopenia).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High fever, frequent infections, persistent sore throat (signs of agranulocytosis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty of breathing or swallowing, rash, itching, hives, dizziness (signs of hypersensitivity, anaphylactic and anaphylactoid reactions).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling mainly of the face and throat (signs of angioedema).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disturbing thoughts or moods (signs of psychotic disorders).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impaired memory (signs of memory impairment).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seizures (signs of convulsions).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anxiety.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stiff neck, fever, nausea, vomiting, headache (signs of aseptic meningitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden and severe headache, nausea, dizziness, numbness, inability or difficulty to speak, weakness or paralysis of limbs or face (signs of cerebrovascular accident or stroke).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty of hearing (signs of impaired hearing).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, dizziness (signs of high blood pressure, hypertension).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash, purplish-red spots, fever, itching (signs of vasculitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden difficulty of breathing and feeling of tightness in chest with wheezing or coughing (signs of asthma or Pneumonitis if fever).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting of blood (signs of hematemesis) and/or black or bloody stools (signs of gastrointestinal hemorrhage).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bloody diarrhea (signs of hemorrhagic diarrhea).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Black stools (signs of melena).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach pain, nausea (signs of gastrointestinal ulcer, bleeding or perforation).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhea, abdominal pain, fever, nausea, vomiting (signs of colitis, including hemorrhagic colitis, ischemic colitis and exacerbation of ulcerative colitis or Crohn`s disease).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe upper stomach pain (signs of pancreatitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellowing of the skin or eyes (signs of jaundice), nausea, loss of appetite, dark urine (signs of hepatitis/liver failure).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flu-like symptoms, feeling tired, muscles aches, increased liver enzymes in blood test results (signs of liver disorders including fulminant hepatitis, hepatic necrosis, hepatic failure).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blister (signs of bullous dermatitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Red or purple skin (possible signs of blood vessel inflammation), skin rash with blisters, blistering of the lips, eyes and mouth, skin inflammation with flaking or peeling (signs of erythema multiforme or if fever signs of Stevens-Johnson syndrome or toxic epidermal necrolysis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash with flacking or peeling (signs of exfoliative dermatitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sensitivity of the skin to sun (signs of photosensitivity reaction).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purple skin patches (signs of purpura or Henoch-Schonlein purpura if caused by an allergy).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling, feeling weak, or abnormal urination (signs of acute renal failure).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Excess of protein in the urine (signs of proteinuria).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swollen face or abdomen, high blood pressure (signs of nephrotic syndrome).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Higher or lower urine output, drowsiness, confusion, nausea (signs of tubulointerstitial nephritis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severely decreased urine output (signs of renal papillary necrosis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generalized swelling (signs of edema).</p><p>If you experience any of these, <strong>tell your doctor straight away.</strong></p><p>Some side effects are common</p><p><em>These side effects may affect between 1 and 10 in every 100 patients</em></p><p>Headache, dizziness, vertigo, nausea, vomiting, diarrhea, indigestion (signs of dyspepsia), abdominal pain, flatulence, loss of appetite (signs of decreased appetite), abnormal liver function test results (e.g. level of transaminases increased), skin rash.</p><p><strong>Some side effects are uncommon</strong></p><p><em>These side effects may affect between 1 and 10 in every 1000 patients</em></p><p>Palpitations, chest pain.</p><p>Some side effects are rare</p><p><em>These side effects may affect between 1 and 10 in every 10,000 patients</em></p><p>Drowsiness (signs of somnolence), stomach pain (signs of gastritis), liver disorder, itchy rash (signs of urticaria).</p><p>Some side effects are very rare</p><p><em>These side effects may affect less than 1 in 10,000 patients</em></p><p>Low level of red blood cells (anemia), low level of white blood cells (leukopenia), disorientation, depression, difficulty sleeping (signs of insomnia), nightmares, irritability, tingling or numbness of the hands or feet (signs of paresthesia), trembling (signs of tremor), taste disorders (signs of dysgeusia), vision disorders* (signs of visual impairment, blurred vision, diplopia), noises in ears (signs of tinnitus), constipation, mouth sores (signs of stomatitis), swollen, red and sore tongue (signs of glossitis), disorder of the tube that carries food from the throat to the stomach (signs of esophageal disorder), upper abdomen cramp specially after eating (signs of intestinal diaphragm disease), itchy, red and burning rash (signs of eczema), skin reddening (signs of erythema), hair loss (signs of alopecia), itching (signs of pruritus), blood in urine (signs of hematuria).</p><p><strong>*Vision disorders:</strong> If symptoms of vision disorders occur during treatment with Voltaren, contact your doctor as an eye examination may be considered to exclude other causes.</p><p>If any of these affects you severely, <strong>tell your doctor</strong>.</p><p>If you notice any other side effects not mentioned in this leaflet, please inform your doctor or pharmacist.</p><p>If you take Voltaren for more than a few weeks, you should make sure to visit your doctor for regular check-ups, to ensure that you are not suffering from unnoticed undesirable effects</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use after the expiry date shown on the box.</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C.</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Protect from moisture.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The <strong>active substance</strong> in Voltaren GR tablets is diclofenac sodium.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The <strong>other ingredients</strong> are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>GR tablets 25 mg</strong>: Cellulose microcrystalline; lactose monohydrate; magnesium stearate; maize starch; povidone; silica, colloidal anhydrous; sodium starch glycolate (type A); hypromellose; iron oxide yellow (E172); macrogoglycerol hydroxystearate; Methacrylic acid &ndash; ethyl acrylate copolymer; macrogol 8000; talc; titanium dioxide (E171); Simeticone; alpha-octadecyl-omega-hydroxy-polyglykolether; sorbic acid.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>GR tablets 50 mg</strong>: Cellulose microcrystalline; lactose monohydrate; magnesium stearate; maize starch; povidone; silica, colloidal anhydrous; sodium starch glycolate (type A); hypromellose; iron oxide red (E172); iron oxide yellow (E172); macrogoglycerol hydroxystearate; Methacrylic acid &ndash; ethyl acrylate copolymer; macrogol 8000; talc; titanium dioxide (E171); Simeticone; alpha-octadecyl-omega-hydroxy-polyglykolether; sorbic acid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Your medicine is called Voltaren and is supplied in the form of a GR tablet. 
Voltaren 25 mg GR tablet is yellow, round, biconvex, with bevelled edges. One side is debossed with “CG”, the other one with “BZ”.
Voltaren 50 mg GR tablet is light brown, round, biconvex, with bevelled edges. One side is debossed with “CG”, the other one with “GT”.
Each tablet contains 25 mg or 50 mg of the active substance diclofenac sodium.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG&nbsp;</p><p>www.Novartis.com&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>ما هو فولتارين</strong></p><p>المادة الفعالة في فولتارين أقراص مقاومة لعصارة المعدة (أقراص GR) هي ديكلوفيناك صوديوم.</p><p>ينتمي فولتارين إلى مجموعة من الأدوية تُسمَّى &quot;الأدوية غير الستيرويدية المضادة للالتهاب&quot; (NSAIDs)، وهي تُستعمَل لعلاج الألم والالتهاب.</p><p>&nbsp;</p><p><strong>ما هي استعمالات فولتارين</strong></p><p><strong><em><u>الأقراص المقاومة لعصارة المعدة (الأقراص </u></em></strong><strong><em><u>GR</u></em></strong><strong><em><u>)</u></em></strong> يمكن أن تُستعمَل لعلاج الحالات التالية:</p><ul><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ألم التهاب المفاصل الروماتيزمي أو الانحلالي (التهاب المفاصل)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ألم الظهر، تجمد الكتف، التهاب مفصل المرفق (الكوع)، والأنواع الأخرى من الروماتيزم.</li><li>&nbsp; &nbsp; &nbsp; &nbsp;نوبات النقرس.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; الالتواء، وشد عضلي، وغيرها من الإصابات.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; الألم والتورم بعد العمليات الجراحية.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; الحالات الالتهابية المؤلمة المتعلقة بأمراض النساء، وتشمل دورات الطمث.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; التهاب الأذن، والأنف، والحلق.</li><li>&nbsp;</li></ul><p><strong>كيف يعمل فولتارين</strong></p><p>يعمل فولتارين على تخفيف أعراض الالتهاب، مثل الألم والتورم، من خلال صد تخليق الجزيئات (البروستاجلاندينات) المسئولة عن الالتهاب، والألم، والحمى. وهو لا يزاول أي تأثير على أسباب الالتهاب أو الحمى.</p><p>إذا كانت لديك أي أسئلة عن الكيفية التي يعمل بها فولتارين أو عن سبب وصف هذا الدواء لك، برجاء أن تسأل طبيبك.</p><p>&nbsp;</p><p><strong>المراقبة أثناء علاجك بواسطة فولتارين</strong></p><p>إذا كان لديك فشل قلب احتقاني خفيف (NYHA-I)، أو مخاطر هامة متعلقة بمرض القلب، سيقوم طبيبك بصفة دورية بإعادة تقييم ما إذا كان ينبغي أن تستمر في استعمال فولتارين، لا سيما إذا كنت تتلقى العلاج لأكثر من 4 أسابيع.</p><p>إذا كان لديك أي خلل في الكبد، أو في الكلى، أو في الدم، ستُجرَى لك اختبارات للدم أثناء العلاج. هذه الاختبارات ستراقب لديك إما وظيفة الكبد (مستوى الترانسأمينيز) أو وظيفة الكلى (مستوى الكرياتينين) أو صورة الدم (عدد خلايا الدم البيضاء والحمراء والصفيحات). سيأخذ طبيبك في اعتباره نتائج هذه الاختبارات ليقرر ما إذا كنت تحتاج إلى وقف استعمال فولتارين أو إلى تغيير الجرعة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>التزم بجميع تعليمات طبيبك بكل دقة. هذه التعليمات قد تكون مختلفة عن المعلومات العامة المذكورة في هذه النشرة.</p><p>&nbsp;</p><p><strong>أ. لا تأخذ فولتارين</strong></p><ul><li>&nbsp; &nbsp; &nbsp;&nbsp;<strong>إذا كانت لديك أرجية</strong> (حساسية مفرطة) تجاه ديكلوفيناك، أو صوديوم ميتابايسالفيت (أو سائر مركبات السالفيت) <strong><em>(فقط المحلول الذي يؤخذ بالحقن) </em></strong>أو أي من المكونات الأخرى في فولتارين المذكورة في نهاية هذه النشرة.</li><li>&nbsp; &nbsp; &nbsp;<strong>إذا كنت قد تعرَّضت</strong> في أي وقت سابق لحدوث تفاعلات أرجية (حساسية) عقب استعمال أدوية لعلاج الالتهاب أو الألم (مثلاً حمض أسيتيل ساليسيليك، أو ديكلوفيناك، أو إيبوبروفين). التفاعلات قد تشمل الربو، الرشح من الأنف، الطفح الجلدي، تورم الوجه. إذا ظننت أن لديك أرجية (حساسية مفرطة) استشر طبيبك.</li><li>&nbsp; &nbsp; &nbsp; &nbsp;<strong>إذا كنت تعاني</strong> من قرحة في المعدة أو في الأمعاء.</li><li>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<strong>إذا كان لديك</strong> نزف أو ثقب في القناة الهضمية، ومن بين أعراضه نزول دم في البراز أو تلون البراز باللون الأسود.</li><li>&nbsp; &nbsp;&nbsp;<strong>إذا كنت تعاني</strong> من فشل في الكلى أو الكبد.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>إذا كنت تعاني </strong>من مرض قلبي مؤكد و/أو مرض في الأوعية الدموية بالدماغ (مثلا إذا كنت قد تعرضت لنوبة قلبية، سكتة دماغية، سكتة دماغية مصغرة (TIA) أو انسداد في وعاء دموي ييصل للقلب أو للدماغ أو عملية لتنظيف أو اجتياز انسدادات.</li><li>&nbsp; &nbsp; &nbsp; &nbsp;<strong>إذا كنت تعاني أو قد عانيت </strong>من مشاكل في الدورة الدموية (اعتلال شرياني محيطي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;<strong>إذا كنتِ </strong>حاملاً في الشهور الثلاثة الأخيرة من الحمل.</li><li>إذا انطبق عليك أي من هذه الأمور، <strong>أخبر طبيبك مع الامتناع عن أخذ فولتارين.</strong></li></ul><p>إذا اشتبهت في أن لديك أرجية (حساسية مفرطة) استشر طبيبك.</p><p><strong>&nbsp;</strong></p><p><strong>ب. يجب توخي الحذر الخاص مع </strong><strong>فولتارين</strong></p><ul><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا كان لديك فشل قلب احتقاني خفيف (NYHA-I)، أو عوامل مخاطرة هامة مثل ارتفاع ضغط الدم، ارتفاع مستويات الدهون (الكولسترول، الجلسريدات الثلاثية) في الدم، مرض السكر، أو إذا كنت مدخناً، وقرر طبيبك أن يصف لك فولتارين، يجب ألا تزيد الجرعة عن 100 مجم في اليوم إذا كنت تتلقى العلاج لأكثر من 4 أسابيع.</li><li>&nbsp; &nbsp; &nbsp; من المهم بصفة عامة أن تأخذ أدنى جرعة من فولتارين قادرة على تخفيف الألم و/أو التورم ولأقصر مدة ممكنة لتقليل مخاطر إصابتك بآثار جانبية إلى أدنى حد ممكن.</li><li>&nbsp; &nbsp; &nbsp; &nbsp;إذا كنت تأخذ فولتارين بالتزامن مع أدوية أخرى مضادة للالتهاب، وتشمل حمض أسيتيل ساليسيليك، الكورتيكوستيرويدات، &quot;الأدوية التي تسبب سيولة الدم&quot;، أو &quot;SSRIs&quot; (انظر &quot;استعمال أدوية أخرى&quot;).</li><li>&nbsp; &nbsp; &nbsp; إذا كنت تعاني من الربو أو حمى القش (التهاب أنفي موسمي أرجي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; إذا كنت قد عانيت في أي وقت سابق من مشاكل في القناة الهضمية مثل قرحة المعدة، أو النزف، أو تلون البراز باللون الأسود، أو إذا كنت قد أُصبت بعناء في المعدة أو حرقان فم المعدة بعد استعمال الأدوية المضادة للالتهاب في الماضي.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا كان لديك التهاب في القولون (التهاب القولون التقرحي) أو في الأمعاء (مرض كرون).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; إذا كانت لديك مشاكل في الكبد أو الكلى.</li><li>&nbsp; &nbsp; &nbsp; &nbsp;إذا كنت تعاني من الجفاف (مثلاً بسبب الاعتلال، أو الإسهال، أو قبل أو بعد العمليات الجراحية الكُبرى).</li><li>&nbsp;إذا كان لديك تورم في القدمين.</li><li>&nbsp; &nbsp;إذا كان لديك خلل يؤدي إلى النزف أو أنواع أخرى من الخلل في الدم، ويشمل ذلك حالة نادرة في الكبد تُسمى بورفيريا.</li><li>&nbsp;إذا أجريت مؤخرًا أو ستخضع لعملية جراحية في المعدة أو الأمعاء.</li></ul><p>إذا انطبق عليك أي من الأمور المذكورة عاليه، <strong>أخبر طبيبك قبل أن تأخذ فولتارين</strong><strong> </strong><strong>أقراص مقاومة لعصارة المعدة (أقراص </strong><strong>GR</strong><strong>)</strong><strong>.</strong></p><ul><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا حدثت لديك في أي وقت أثناء استعمال فولتارين أي علامات أو أعراض لمشاكل في القلب أو الأوعية الدموية مثلاً في شكل ألم في الصدر، ضيق في التنفس، ضعف، أو تداخل الكلام وعدم وضوحه، اتصل فوراً بطبيبك.</li><li>&nbsp; &nbsp; قد يؤدي فولتارين إلى تقليل أعراض العدوى (مثل الصداع، ارتفاع حرارة الجسم) وبالتالي فإنه قد يُزيد من صعوبة اكتشاف العدوى وعلاجها بالشكل المناسب. إذا شعرت بأنك مريض وتحتاج أن تذهب إلى الطبيب، لا تنسى أن تُخبره بأنك تأخذ فولتارين.</li><li>&nbsp; &nbsp; &nbsp; في حالات نادرة جداً، قد يؤدي فولتارين، شأنه شأن سائر الأدوية المضادة للالتهاب، إلى حدوث تفاعلات أرجية (حساسية) شديدة في الجلد (مثلاً في شكل طفح).</li></ul><p>إذا حدث لديك أي من الأعراض المذكورة عاليه، <strong>أخبر طبيبك فوراً</strong>.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>ج. استعمال أدوية أخرى</strong></p><ul><li>من المهم على نحو خاص أن تخبر طبيبك إذا كنت تستعمل أي من الأدوية التالية:</li><li>&nbsp; &nbsp;الليثيوم أو المثبطات الانتقائية لإعادة التقاط السيروتونين (SSRIs) (أدوية تُستعمَل لعلاج بعض أنواع الاكتئاب).</li><li>&nbsp; &nbsp; &nbsp;ديجوكسين (دواء يُستعمَل في أمراض القلب).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; مدرات البول (أدوية تُستعمل لزيادة كمية البول).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مثبطات ACE أو حاصرات البيتا (فئات من الأدوية تُستعمَل لعلاج ضغط الدم المرتفع والفشل القلبي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;الأدوية الأخرى المضادة للالتهاب مثل حمض أسيتيل ساليسيليك أو إيبوبروفين.</li><li>&nbsp; &nbsp; &nbsp;الكورتيكوستيرويدات (أدوية تُستعمَل لتخفيف الالتهاب في المناطق الملتهبة من الجسم).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;&quot;الأدوية التي تسبب سيولة الدم&quot; (أدوية تُستعمَل لمنع تجلط الدم).</li><li>&nbsp; الأدوية (مثل الميتفورمين) التي تُستعمَل لعلاج مرض السكر، باستثناء الأنسولين.</li><li>&nbsp; &nbsp; ميثوتريكسات (دواء يُستعمَل لعلاج بعض أنواع السرطان أو التهاب المفاصل).</li><li>&nbsp; &nbsp; &nbsp; سيكلوسبورين، تاكروليماس (أدوية تُستعمَل أساساً في المرضى الذين تلقوا زرع أعضاء).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ترايميثوبريم (دواء يُستعمَل للوقاية أو لعلاج عدوى المسالك البولية).</li><li>&nbsp; &nbsp; مضادات البكتريا من نوع الكينولون (أدوية تُستعمَل ضد العدوى).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; فوريكونازول (دواء يُستعمَل لعلاج العدوى الفطرية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;فينيتوين (دواء يُستعمَل لعلاج التشنجات).</li><li>&nbsp; &nbsp; ريفامبيسين (مضاد حيوي يستعمل لعلاج العدوى البكتيرية).</li><li>&nbsp; &nbsp; &nbsp;أخبر طبيبك أو الصيدلي إذا كنت تستعمل حالياً أو استعملت منذ فترة قصيرة أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها بدون تذكرة طبية.</li><li>&nbsp;</li></ul><p><strong>د. استعمال فولتارين مع الطعام والشراب</strong></p><p><strong><em><u>الأقراص المقاومة لعصارة المعدة (الأقراص </u></em></strong><strong><em><u>GR</u></em></strong><strong><em><u>)</u></em></strong></p><p>&nbsp; &nbsp; &nbsp; &nbsp;أقراص فولتارين GR يجب أن تُبلَع صحيحة مع كوب من الماء أو غيره من السوائل.</p><p>&nbsp; &nbsp; يوصَى بأخذ أقراص فولتارين GR قبل الأكل أو على معدة خاوية.</p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>&nbsp;</em></strong><strong>المسنون</strong></p><p>قد يكون المرضى المسنون، خاصة ممن يعانون من انخفاض الوزن، أكثر حساسية لآثار فولتارين عن البالغين الآخرين. يجب عليهم الالتزام بتعليمات الطبيب بكل دقة وأن يأخذوا أقل جرعة تصلح للحالة التي يعانون منها. من المهم على نحو خاص أن يقوم المرضى المسنون بإبلاغ طبيبهم فوراً عن أي آثار غير مرغوبة.</p><p><strong>&nbsp;</strong></p><p><strong>الأطفال والمراهقون</strong></p><p>نظراً لقوتها، فلا ينبغي استعمال أقراص فولتارين GR 50 مجم في الأطفال والمراهقين تحت 14 سنة من العمر. فيمكن مثلاً استعمال أقراص فولتارين GR 25 مجم في المرضى تحت 14 سنة من العمر. لا ينبغي استعمال أقراص فولتارين GR في الأطفال تحت 12 شهراً من العمر.</p><p>&nbsp;</p><p>هـ.&nbsp;&nbsp;<strong>الحمل والإرضاع</strong></p><p dir="RTL">يجب أن تخبري طبيبك إذا كنت حاملاً، أو إذا اشتبهت في أنك حامل. يجب ألا تأخذي أقراص مقاومة لعصارة المعدة (أقراص GR) أثناء الحمل ما لم تكن هناك ضرورة حتمية.</p><p dir="RTL">شأنه شأن سائر الأدوية المضادة للالتهاب، يجب ألا تأخذي فولتارين أقراص مقاومة لعصارة المعدة (أقراص GR) خلال الـ 3 شهور الأخيرة من الحمل، حيث أنه قد يؤذي الجنين ويسبب مشاكل عند الولادة.</p><p dir="RTL">يجب أن تخبري طبيبك إذا كنتِ مرضعة.</p><p dir="RTL">يجب أن تمتنعي عن الإرضاع أثناء أخذ فولتارين، وذلك لأنه قد يؤذي الرضيع.</p><p dir="RTL">سيناقش معك طبيبك المخاطر الممكنة التي قد تترتب على أخذ فولتارين أثناء الحمل أو الإرضاع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong><strong>النساء القادرات على الإنجاب</strong></p><p dir="RTL">عند استعمال فولتارين قد يصبح من الأصعب للمرأة أن تحمل. لا تستعملي فولتارين أقراص مقاومة لعصارة المعدة (أقراص GR) إلا في الضرورة القصوى، إذا كنتِ تخططين للحمل أو إذا كانت لديك مشاكل في أن تحملي.</p><p>&nbsp;</p><p><strong>&nbsp;</strong><strong>النساء القادرات على الإنجاب</strong></p><p>عند استعمال فولتارين قد يصبح من الأصعب للمرأة أن تحبل. لا تستعملي فولتارين أقراص مقاومة لعصارة المعدة (أقراص GR) إلا في الضرورة القصوى، إذا كنتِ تخططين للحمل أو إذا كانت لديك مشاكل في أن تحبلي.</p><p>&nbsp;</p><p><strong>ج. الاستعمال أثناء القيادة واستخدام الآلات</strong></p><p>إذا كنت تعاني من أي اضطرابات في الرؤية أو شعور بالدوار أو النعاس خلال أخذ الفولتارين، يجب أن تتجنب القيادة أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>التزم بتعليمات طبيبك بكل دقة. لا تتجاوز الجرعة الموصَى بها.</p><p>&nbsp;</p><p><strong>ما هي الكمية التي ينبغي أن تأخذها من فولتارين</strong></p><p>لا تتجاوز الجرعة الموصَى بها التي وصفها لك طبيبك. من المهم أن تستعمل أدنى جرعة قادرة أن تسيطر على ألمك وألا تأخذ أقراص مقاومة لعصارة المعدة (أقراص GR) لمدة أطول من اللازم.</p><p>سوف يخبرك طبيبك بالضبط كم عدد الأقراص GR التي يجب أن تستعملها من فولتارين. بناء على مدى استجابتك للعلاج، قد يقترح طبيبك جرعة أكبر أو أقل.</p><p><strong>البالغون</strong></p><p>في بداية العلاج تكون الجرعة اليومية بصفة عامة 100 إلى 150 مجم. في الحالات الأخف، وفي العلاج طويل الأجل، يكفي عادة استعمال 75 إلى 100 مجم يومياً. يتم عادةً تقسيم الجرعة اليومية إلى 2 إلى 3 جرعات منفصلة. لا تتجاوز الجرعة 150 مجم في اليوم. في حالات الطمث المؤلم، ابدأي العلاج بالجرعة 50 إلى 100 مجم مع ظهور أولى الأعراض. استمري بالجرعة 50 مجم حتى ثلاث مرات في اليوم لبضعة أيام، حسب اللازم. إذا لم تحقق الجرعة اليومية 150 مجم القدر الكافي من تخفيف الألم على مدى 2 إلى 3 دورات طمث، فإن طبيبك قد يوصي بإعطائك حتى 200 مجم يومياً خلال دورات الطمث اللاحقة. لا ينبغي تجاوز الجرعة 200 مجم في اليوم.</p><p>&nbsp;</p><p><strong>الأطفال والمراهقون</strong></p><p>الأطفال ابتداء من عمر سنة واحدة فأكثر والمراهقون يتم إعطاؤهم 0.5 إلى 2 مجم لكل كيلوجرام من وزن الجسم يومياً، وتُعطَى مقسَّمة إلى 2 إلى 3 جرعات منفصلة، وفقاً لشدة المرض.</p><p>لا ينبغي تجاوز الجرعة 150 مجم في اليوم.</p><p>مثال: إذا كان وزن الطفل 20 كيلوجرام، فيتم عندئذ إعطاؤه جرعة يومية 10 إلى 40 مجم. لعلاج التهاب المفاصل الروماتويدي الصبياني، يمكن زيادة الجرعة اليومية حتى حد أقصى 3 مجم لكل كيلوجرام من وزن الجسم، تُعطَى مقسَّمة إلى عدة جرعات منفصلة.</p><p><strong>&nbsp;</strong></p><p><strong>متى ينبغي أن تأخذ فولتارين</strong></p><p>يوصَى بتناول أقراص فولتارين GR قبل الأكل أو على معدة خاوية.</p><p>&nbsp;</p><p><strong>كيف تأخذ فولتارين</strong></p><p>يجب أن تُبلَع أقراص فولتارين GR صحيحة مع كوب من الماء أو غيره من السوائل.</p><p>يوصَى بتناول أقراص فولتارين GR قبل الأكل أو على معدة خاوية. لا تقسم القرص ولا تمضغه.</p><p><strong>ما هي مدة أخذ فولتارين</strong></p><p>التزم بتعليمات طبيبك بكل دقة.</p><p>إذا استعملت فولتارين لأكثر من بضعة أسابيع، يجب أن تحرص على زيارة طبيبك للفحوصات الدورية، لكي تتأكد من أنك لا تعاني من آثار جانبية غير ملحوظة.</p><p>إذا كانت لديك أسئلة عن مدة استعمال فولتارين، تحدث مع طبيبك أو مع الصيدلي.</p><p>&nbsp;</p><p><strong>إذا أخذت فولتارين بأكثر مما ينبغي</strong></p><p>إذا أخذت فولتارين بأكثر مما ينبغي على سبيل الخطأ، <strong>أخبر طبيبك أو الصيدلي أو اذهب فوراً إلى وحدة الطوارئ بالمستشفى.</strong></p><p>فإنك قد تحتاج إلى رعاية طبية.</p><p>&nbsp;</p><p><strong>إذا نسيت أن تأخذ فولتارين</strong></p><p>إذا نسيت أن تأخذ إحدى الجرعات، خذها بمجرد أن تتذكرها. وإذا كان موعد جرعتك التالية قد اقترب، يمكنك أن تأخذ القرص التالي في موعده المعتاد. لا تأخذ جرعة مضاعفة للتعويض عن الجرعة المنسية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن جميع الأدوية، فإن المرضى الذين يستعملون فولتارين قد يتعرضون لحدوث آثار جانبية، غير أنها لا تحدث لجميع الأشخاص.</p><p>&nbsp;</p><p><strong>بعض الآثار الجانبية قد تكون خطيرة</strong></p><p><em>هذه الآثار الجانبية غير الشائعة قد تصيب بين 1 و 10 من كل 1000 مريض، لا سيما عند استعمال جرعة يومية عالية (150 مجم) لفترة زمنية طويلة</em></p><ul><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ألم وضيق مفاجئ في الصدر (علامات احتشاء عضلة القلب أو النوبة القلبية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; انقطاع التنفس، صعوبة التنفس عند الاستلقاء، تورم القدمين أو الساقين (علامات الفشل القلبي).</li></ul><p>&nbsp;</p><p><em>هذه الآثار الجانبية النادرة أو النادرة جداً قد تصيب من أقل من 1 إلى 10 من كل 10000 مريض</em></p><ul><li>&nbsp; &nbsp; &nbsp;&nbsp; &nbsp; نزف تلقائي أو كدمة (من علامات نقص الصفيحات).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; حمى مرتفعة، عدوى متكررة، التهاب مستمر في الحلق (من علامات انعدام الخلايا الحبيبية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; صعوبة في التنفس أو في البلع، طفح، حكة، أرتيكاريا، دوخة (من علامات الحساسية المفرطة، والتفاعلات الاستهدافية والتأقانية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;تورم أساساً في الوجه والحلق (من علامات الوذمة الوعائية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;خلل في الأفكار أو المزاج (من علامات الاضطرابات الذهانية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; ضعف الذاكرة (من علامات خلل الذاكرة).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; تشنجات (من علامات الاختلاجات).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; قلق.</li><li>&nbsp; &nbsp; &nbsp; تيبس العنق، حمى، غثيان، قيء، صداع (من علامات الالتهاب السحائي الطاهر).</li><li>&nbsp; &nbsp; &nbsp;صداع مفاجئ وشديد، غثيان، دوخة، تنميل، عدم القدرة على الكلام أو صعوبة الكلام، ضعف أو شلل في الأطراف أو الوجه (من علامات حدوث حادث دماغي وعائي أو سكتة دماغية).</li><li>&nbsp; &nbsp; صعوبة في السمع (من علامات ضعف السمع).</li><li>&nbsp; &nbsp; &nbsp;صداع، دوخة (من علامات ارتفاع ضغط الدم).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; طفح، بقع حمراء تميل إلى اللون الأرجواني، حمى، حكة (من علامات التهاب الأوعية).</li><li>&nbsp; &nbsp; &nbsp; صعوبة مفاجئة في التنفس والشعور بضيق في الصدر مع أزيز أو سعال (من علامات الربو أو التهاب الرئة إذا كان مصحوباً بحمى).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;قيء دموي و/أو براز أسود أو دموي (من علامات النزف من القناة الهضمية).</li><li>&nbsp; &nbsp;إسهال دموي (من علامات الإسهال المصحوب بنزف).</li><li>&nbsp; &nbsp;براز أسود (من علامات التغوط الأسود).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;ألم في المعدة، غثيان (من علامات قرحة القناة الهضمية).</li><li>&nbsp; &nbsp; &nbsp;إسهال، ألم بطني، حمى، غثيان، قيء (من علامات التهاب القولون، ويشمل ذلك التهاب القولون النزفي، التهاب القولون الإقفاري وتفاقم التهاب القولون التقرحي أو مرض كرون).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ألم شديد في منطقة أعلى المعدة (من علامات التهاب البنكرياس).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;اصفرار الجلد أو العينين (من علامات اليرقان)، غثيان، فقدان الشهية، بول داكن (من علامات الالتهاب الكبدي/ الفشل الكبدي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; أعراض شبيهة بالأنفلونزا، شعور بالتعب، آلام عضلية، ارتفاع الإنزيمات الكبدية في نتائج اختبارات الدم (من علامات اضطرابات الكبد وتشمل الالتهاب الكبدي الخاطف، والنخر الكبدي، والفشل الكبدي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;بثور (من علامات الالتهاب الجلدي الفقاعي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;تلوُّن الجلد باللون الأحمر أو الأرجواني (علامات قد تدل على التهاب الأوعية الدموية)، طفح جلدي مع بثور، بثور في الشفتين، والعينين، والفم، التهاب الجلد مع تقشره أو انفصال طبقات منه (من علامات الحمامي المتعددة الأشكال أو إذا كانت مصحوبة بحمى فهي تدل على متلازمة ستيفنس جونسون أو الانحلال الجلدي السُمي الناخر).</li><li>&nbsp; &nbsp; &nbsp; طفح جلدي مع تقشره أو انفصال طبقات منه (من علامات الالتهاب الجلدي التقشري).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;زيادة حساسية الجلد للشمس (من علامات تفاعل الحساسية الضوئية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; بقع أرجوانية في الجلد (من علامات الفرفرية أو فرفرية هينوك شونلاين إذا كانت ناتجة عن أرجية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; تورم، شعور بالضعف، أو خلل في التبول (من علامات الفشل الكلوي الحاد).</li><li>&nbsp; &nbsp; &nbsp; &nbsp;زيادة إفراز البروتين في البول (من علامات البيلة البروتينية).</li><li>&nbsp; &nbsp; &nbsp; تورم الوجه أو البطن، ارتفاع ضغط الدم (من علامات المتلازمة الكلائية).</li><li>&nbsp; &nbsp; زيادة أو نقص إفراز البول، نعاس، تشويش، غثيان (من علامات الالتهاب الخلالي في النبيبات الكلوية).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; نقص شديد في إفراز البول (من علامات النخر الحليمي الكلوي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;تورم عام (من علامات الوذمة).</li><li>إذا حدث لديك أي من هذه الآثار الجانبية، <strong>أخبر طبيبك فوراً</strong>.</li></ul><p>&nbsp;</p><p><strong>بعض الآثار الجانبية شائعة</strong></p><p><em>هذه الآثار الجانبية قد تصيب بين 1 و 10 من كل 100 مريض</em></p><p>صداع، دوخة، دوار، غثيان، قيء، إسهال، سوء هضم (من علامات عُسر الهضم)، ألم بطني، انتفاخ، فقدان الشهية (من علامات نقص الشهية)، خلل في نتائج اختبارات الوظيفة الكبدية (مثلاً زيادة مستوى الترانسأمينيز)، طفح جلدي.</p><p>&nbsp;</p><p><strong>بعض الآثار الجانبية غير شائعة</strong></p><p><em>هذه الآثار الجانبية قد تصيب بين 1 و 10 من كل 1000 مريض</em></p><p>خفقان، ألم في الصدر.</p><p>&nbsp;</p><p><strong>بعض الآثار الجانبية نادرة</strong></p><p><em>هذه الآثار الجانبية قد تصيب بين 1 و 10 من كل 10000 مريض</em></p><p>نعاس (من علامات الميل للنعاس)، ألم في المعدة (من علامات التهاب المعدة)، خلل في الكبد، طفح مصحوب بحكة (من علامات الأرتيكاريا).</p><p><strong>بعض الآثار الجانبية نادرة جداً</strong></p><p><em>هذه الآثار الجانبية قد تصيب أقل من 1 من بين 10000 مريض</em></p><p>نقص مستوى خلايا الدم الحمراء (أنيميا)، نقص مستوى خلايا الدم البيضاء، توهان، اكتئاب، صعوبة في النوم (من علامات الأرق)، كوابيس، تهيج، خدر أو تنميل في اليدين أو القدمين (من علامات تشوش الحس)، رعشة، خلل في المذاق (من علامات خلل حاسة التذوق)، اضطرابات بصرية* (من علامات الخلل البصري، غشاوة الإبصار، ازدواج الرؤية)، ضوضاء في الأذنين (من علامات الطنين)، إمساك، قروح في الفم (من علامات التهاب الفم)، تورم واحمرار واحتقان اللسان (من علامات التهاب اللسان)، خلل في الأنبوبة التي تحمل الطعام من الحلق إلى المعدة (من علامات خلل المريء)، تقلص في أعلى البطن لا سيما بعد الأكل (من علامات المرض المعوي الحجابي)، طفح أحمر حارق مصحوب بحكة (من علامات الإكزيما)، احمرار الجلد (من علامات الحمامي)، سقوط الشعر، حكة، دم في البول (من علامات البيلة الدموية).</p><p>*<strong> إضطرابات الرؤية:</strong> إذا ظهرت أعراض اضطراب الرؤية خلال فترة العلاج بكتافلام، راجع طبيبك فقد تحتاج إلى فحص العين، كي يتم استبعاد أي أسباب أخرى.</p><p>إذا حدثت لديك إصابة شديدة بأي من هذه الآثار الجانبية، <strong>أخبر طبيبك.</strong></p><p>إذا لاحظت أي آثار جانبية أخرى غير مذكورة في هذه النشرة، برجاء أن تخبر طبيبك أو الصيدلي.</p><p>إذا استعملت فولتارين لأكثر من بضعة أسابيع، يجب أن تحرص على زيارة طبيبك للفحوصات الدورية، لكي تتأكد من أنك لا تعاني من آثار جانبية مناوئة غير ملحوظة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li>&nbsp; &nbsp; &nbsp; &nbsp; يُحفظ لا ينبغي استعماله بعد تاريخ انتهاء الصلاحية المذكور على العلبة.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; يُحفَظ في درجة حرارة لا تزيد عن 30&deg;م.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; يُحفظ بعيداً عن متناول ومرأى الأطفال.</li><li><p dir="RTL">●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدًا عن الرطوبة.&nbsp;</p></li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لمادة الفعالة</strong> في أقراص فولتارين GR هي ديكلوفيناك صوديوم.</p><p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>المكونات الأخرى</strong> هي:</p><p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الأقراص </strong><strong>GR</strong><strong> 25 مجم:</strong> سيليلوز دقيق التبلور؛ لاكتوز مونوهيدرات؛ ستيارات ماغنسيوم؛ نشا الذرة؛ بوفيدون؛ سيليكا غروانية لامائية؛ صوديوم نشا جلايكولات (النوع A)؛ هيبروميللوز؛ أكسيد الحديد الأصفر (E172)؛ ماكروجوجليسرول هيدروكسي ستيارات؛ حمض ميثاكريليك- إيثيل أكريلات كوبوليمر؛ ماكروجول 8000؛ تلك؛ ثاني أكسيد التيتانيوم (E171)؛ سيميتيكون؛ ألفا- أوكتاديسيل- أوميجا- هيدروكسي- بوليجلايكولإيثير؛ حمض سوربيك.</p><p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الأقراص </strong><strong>GR</strong><strong> 50 مجم:</strong> سيليلوز دقيق التبلور؛ لاكتوز مونوهيدرات؛ ستيارات ماغنسيوم؛ نشا الذرة؛ بوفيدون؛ سيليكا غروانية لامائية؛ صوديوم نشا جلايكولات (النوع A)؛ هيبروميللوز؛ أكسيد الحديد الأحمر (E172)؛ أكسيد الحديد الأصفر (E172)؛ ماكروجوجليسرول هيدروكسي ستيارات؛ حمض ميثاكريليك- إيثيل أكريلات كوبوليمر؛ ماكروجول 8000؛ تلك؛ ثاني أكسيد التيتانيوم (E171)؛ سيميتيكون؛ ألفا- أوكتاديسيل- أوميجا- هيدروكسي- بوليجلايكولإيثير؛ حمض سوربيك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>إن دواءك يُسمى فولتارين، وهو متوافر في شكل قرص GR. قرص فولتارين GR 25 مجم هو قرص أصفر، مستدير، ثنائي التحدب، ذو حواف مشطوفة، ومنقوش على أحد جانبيه العلامة &quot;CG&quot;، وعلى الجانب الآخر العلامة &quot;BZ&quot;. قرص فولتارين GR 50 مجم هو قرص بني فاتح، مستدير، ثنائي التحدب، ذو حواف مشطوفة، ومنقوش على أحد جانبيه العلامة &quot;CG&quot;، وعلى الجانب الآخر العلامة &quot;GT&quot;. يحتوي كل قرص على 25 مجم أو 50 مجم من المادة الفعالة ديكلوفيناك صوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>صاحب حق التسويق لهذا المنتج هو نوفارتيس فارما اي جي</p><p>www.Novartis.com&nbsp;<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            04/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Voltaren 50mg gastro-resistant tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active substance is sodium-[o-[(2,6 - dichlorophenyl)-amino]-phenyl]-acetate (= diclofenac sodium). Each gastro-resistant tablet contains 50 mg of diclofenac sodium.
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastro - resistant tablet.

Voltaren 50 mg gastro-resistant tablets - light brown, round, biconvex, with bevelled edges. One side with debossed “CG”, the other with “GT”.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of:</p><ul><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis,</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;painful syndromes of the vertebral column,</li><li>&nbsp;</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non- articular rheumatism.</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute attacks of gout.</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Post-traumatic and post-operative pain, inflammation and swelling, e.g. following dental or orthopaedic surgery.</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Painful and/or inflammatory conditions in gynecology, e.g. primary dysmenorrhea or adnexitis.</li><li>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As an adjuvant in severe painful inflammatory infections of the ear, nose or throat, e.g. pharyngotonsillitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p>As a general recommendation, the dose should be individually adjusted. Adverse effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4 Special warnings and precautions for use).</p><p>&nbsp;</p><p><strong>Adults</strong></p><p>The starting dose for Voltaren gastro-resistant tablets is usually dose is 100 to 150 mg. In milder cases, as well as for long-term therapy, 75 to 100 mg daily is usually sufficient.</p><p>&nbsp;</p><p>The total daily amount is generally given in 2 to 3 divided doses. In order to avoid nocturnal pain and&nbsp; morning stiffness, treatment with tablets during the daytime can be supplemented by the administration of a suppository at bedtime (up to a total maximum daily dose of 150 mg).</p><p>&nbsp;</p><p>In primary dysmenorrhea, the daily dose should be individually adjusted and is generally 50 to 150 mg/ day. Treatment should be started at 50-100&nbsp;mg/day and, if necessary, may increased over the course of several menstrual cycles up to a maximum of 150 mg/day.</p><p>&nbsp;</p><p>&nbsp;</p><p>The gastro-resistant tablets should be swallowed with liquid, preferably before meals; they must not be divided or chewed.</p><p><u>Special populations</u> Pediatrics</p><p>Children aged 1 year or older and adolescents, the daily dosagedepending on the severity of the disorder is 0.5 to 2 mg/kg body weight given in 2 to 3 divided doses,. For treatment of juvenile rheumatoid arthritis, the daily dose can be increased up to a maximum of 3 mg/kg body weight, iven in several divided doses.</p><p>&nbsp;</p><p>The maximum daily dose of 150 mg should not be exceeded.</p><p>Voltaren must not be given to children under 1&nbsp;year of age.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Voltaren 50 mg gastro-resistant tablets are not recommended for use in children Because of their dosage strength</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Voltaren 25 mg gastro-resistant tablets may be used in these patients.</p><p>&nbsp;</p><p>Elderly patients (aged 65 or above)</p><p>No adjustment of the starting dose is generally required for elderly patients. However, caution is indicated on basic medical grounds, especially for frail elderly patients or those with a low body weight (see section 4.4 Special warnings and special precautions for use).</p><p>&nbsp;</p><p><strong><em>Established cardiovascular disease or significant cardiovascular risk factors</em></strong></p><p><em>Treatment with Voltaren is generally not recommended in patients with established cardiovascular disease or uncontrolled hypertension. If needed, patients with established cardiovascular disease, uncontrolled hypertension or significant risk factors for cardiovascular disease should be treated with Voltaren only after careful consideration, and </em>&nbsp; only at doses of up to 100 mg daily if treated for more than 4 weeks (see section 4.4 Special warnings and special precautions for use).</p><p><strong>&nbsp;</strong></p><p><strong>Renal impairment</strong></p><p>Voltaren gastro-resistant tablets is contraindicated in patients with renal failure (GFR &lt;15&nbsp;ml/min/1.73&nbsp;m<sup>2</sup>) (see section 4.3 Contraindications).</p><p>No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Voltaren gastro-resistant tablets to patients with mild to moderate renal impairment (see sections 4.4 Special warnings and special precautions for use).</p><p>&nbsp;</p><p><strong>Hepatic impairment</strong></p><p>Voltaren gastro-resistant tablets is contraindicated in patients with hepatic failure (see section 4.3 Contraindications).</p><p>No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Voltaren gastro-resistant tablets to patients with mild to moderate hepatic impairment (see sections 4.4 Special warnings and special precautions&nbsp; for use).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to to the active substance or to any of the excipients listed in section 6.1.
-	A history of bronchospasm, angioedema, urticaria, acute rhinitis, nasal polyps or allergy-like symptoms after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs. 
-	Third trimester of pregnancy. )see 4.6 Fertility, Pregnancy and lactation)
-	Active gastric and/or duodenal ulcer, gastrointestinal bleeding or perforation.
-	Inflammatory bowel disease (such as Crohn’s disease or ulcerative colitis).
-	Hepatic failure (Child-Pugh class C) (cirrhosis of the liver and ascites).
-	Renal failure (GFR <15 ml/min/1.73 m2).
-	Heart failure (NYHA III-IV).
-	Treatment of post-operative pain after coronary bypass surgery(or use of a heart-lung machine).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General warning for the use of systemic non-steroidal anti-inflammatory drugs </strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>Gastrointestinal ulceration, bleeding or perforation may occur at any time during treatment with non-steroidal anti-inflammatory drugs (NSAIDs), whether COX-2 selective or not, even in the absence of warning symptoms or a predisposing history. To minimise this risk, the lowest effective dose should be given for the shortest possible duration of treatment.</p><p>&nbsp;</p><p>Placebo-controlled studies have shown an increased risk of thrombotic cardiovascular and cerebrovascular complications with certain COX-2 selective inhibitors. It is not yet known whether this risk correlates directly with the COX-1&nbsp;/&nbsp;COX-2 selectivity of individual NSAIDs. As no comparable clinical study data are available at present for long-term treatment with the maximum dosage of diclofenac, the possibility of a similarly elevated risk cannot be ruled out. Until such data becomes available, a careful risk-benefit assessment must be carried out prior to using diclofenac in patients with clinically confirmed coronary heart disease, cerebrovascular disorders, peripheral arterial occlusive disease or considerable risk factors (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking). Due to this risk, too, the lowest effective dose should be given for the shortest possible duration of treatment.</p><p>&nbsp;</p><p>The renal effects of NSAIDs include fluid retention with oedema and/or arterial hypertension. For this reason,&nbsp;</p><p>diclofenac should be used with caution in patients with cardiac impairment and other conditions that predispose to fluid retention. Caution is also indicated in patients who take concomitant diuretics or ACE inhibitors, or who are at increased risk of hypovolaemia.</p><p>The consequences are generally more serious in the elderly. If gastrointestinal bleeding or ulceration occurs in patients undergoing treatment with Voltaren, the medicinal product should be withdrawn.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Skin (Cutaneous) reactions</strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including Voltaren gastro-resistant tablets (see section 4.8 Undesirable effects). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring in the majority of cases within the first month of treatment. Voltaren gastro-resistant tablets should be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity.</p><p>&nbsp;</p><p>As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur in rare cases with diclofenac without earlier exposure to the drug.</p><p>&nbsp;</p><p><strong>Mask sighs of infection</strong></p><p>Its pharmacodynamic properties mean that, Like other NSAIDs, Diclofenac may mask the signs and symptoms of infection.</p><p>&nbsp;</p><p>Precautions</p><p>General</p><p>&nbsp;</p><p>The concomitant use of Voltaren gastro-resistant tablets with systemic NSAIDs including cyclooxygenase-2 selective inhibitors, should be avoided due to the potential for additive adverse effects (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>&nbsp;</p><p>Caution is required in the elderly on basic medical grounds. In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight.</p><p>&nbsp;</p><p>Voltaren gastro-resistant tablets contain lactose. Patients with rare hereditary galactose intolerance, severe lactase deficiency or glucose &ndash; galactose malabsorption should not take Voltaren gastro-resistant tablets. .</p><p>&nbsp;</p><p><strong>Respiratory effects</strong> (<strong>Pre-existing asthma)</strong></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis- like symptoms), reactions on NSAIDs like asthma exacerbations (analgesic intolerance / analgesic- induced asthma), Quincke&rsquo;s oedema or urticaria are more frequent than in other patients. Therefore, particular caution is required in such patients (emergency readiness). This also applies to patients with allergic reactions &ndash; e.g. rash, pruritus or urticaria &ndash; to other substances.</p><p>&nbsp;</p><p><strong>Gastrointestinal effects</strong></p><p>As with all NSAIDs, including diclofenac, close medical surveillance is required and particular caution should be exercised when prescribing Voltaren gastro-resistant tablets in patients with symptoms indicative of gastrointestinal (GI) disorders or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation, (see section 4.8 Undesirable effects). The risk of GI bleeding is higher with increasing NSAID doses and in patients with a history of ulcer (particularly if complicated with bleeding or perforation) and in the elderly patients.</p><p>&nbsp;</p><p>Treatment should be initiated and maintained at the lowest effective dose in order to reduce the risk of GI toxicity in patients with a history of ulcer (particularly if complicated by bleeding or perforation), and in elderly pateints,</p><p>&nbsp;</p><p><em>Combination therapy with protective agents (e.g. proton pump inhibitors or misoprostol) should be considered for </em>&nbsp;these patients, and also for patients requiring concomitant use of low-dose acetylsalicylic acid (ASA), or other drugs likely to increase gastrointestinal risk.</p><p>&nbsp;</p><p>Patients with a history of GI toxicity, particularly&nbsp; elderly patients, should report any unusual abdominal symptoms (especially GI bleeding). Caution required in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants, anti-platelet agents or selective serotonin-reuptake inhibitors (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>&nbsp;</p><p>NSAIDs, including diclofenac, can be associated with an increased risk of a gastrointestinal anastomosis leak. Caution is required with the use of Voltaren after gastrointestinal surgery and close medical monitoring is recommended.</p><p><strong>Hepatic effects</strong></p><p>Close medical surveillance is required when giving Voltaren gastro-resistant tablets to patients with impaired hepatic function, as their condition may be exacerbated. (see section 4.8 Undesirable effects).</p><p>&nbsp;</p><p>As with all NSAIDs, including diclofenac, levels of one or more liver enzymes may rise during treatment with Voltaren&nbsp;This has been observed very frequently with diclofenac in clinical studies (in approximately 15% of patients), but is very rarely accompanied by clinical symptoms. Most of these cases involve borderline increases. Frequently (in 2.5% of cases) the increases observed were moderate (&ge; 3 to &lt;&nbsp;8&nbsp;times the upper limit of normal), while the incidence of marked increases (&ge; 8&nbsp;times the upper limit of normal) remained around 1%. Elevated liver enzyme levels were accompanied by clinically manifest liver damage in 0.5% of cases in the above-mentioned clinical studies. Elevated enzyme levels were generally reversible after discontinuation of the drug.</p><p>&nbsp;</p><p>As with other NSAIDs long-term treatment with Voltaren gastro-resistant tablets required for regular monitoring of liver enzyme levels.</p><p>&nbsp;</p><p>Voltaren gastro-resistant tablets should be discontinued, If abnormal liver function tests persist or worsen, if clinical signs or symptoms suggestive of liver disease develop, or if other manifestations occur (e.g. eosinophilia, rash).</p><p>&nbsp;</p><p>In addition to elevated liver enzymes, there have been rare reports of severe hepatic reactions, including jaundice and fulminant hepatitis, hepatic necrosis and hepatic failure which, in isolated cases, had a fatal outcome.</p><p>&nbsp;</p><p>Hepatitis may develop without prodromal symptoms. Caution is required when using Voltaren gastro-resistant tablets in patients with hepatic porphyria, since it may trigger an attack.</p><p>&nbsp;</p><p><strong>Renal effects</strong></p><p>Owing to the importance of prostaglandins in maintaining renal blood flow, prolonged treatment with high doses of NSAIDs, including diclofenac, frequently (1&ndash;10%) results in oedema and hypertension., particular caution is required in patients with impaired cardiac or renal function, in patient with history of hypertension, in elderly patient, in patients receiving concomitant treatment with diuretics or medicinal products that may significantly impact renal function, and in patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications).</p><p>Monitoring of renal function is recommended as a precautionary measure when using Voltaren gastro-resistant tablets in such cases. Patients usually recover to their pre-treatment state following discontinuation of therapy.</p><p><strong>Cardiovascular effects</strong></p><p>Treatment with NSAIDs including diclofenac, particularly at high doses and for prolonged periods , may be associated with a slightly increased risk of serious cardiovascular thrombotic events (including myocardial infarction and stroke).</p><p>Treatment with Voltaren is generally not recommended in patients with established cardiovascular disease (heart failure, established ischaemic heart disease, peripheral arterial disease) or uncontrolled hypertension. If needed, patients with established cardiovascular disease, uncontrolled hypertension or significant risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus and smoking) should be treated with Voltaren only after careful consideration and only at doses of up to 100 mg daily if treated for more than 4 weeks.</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the lowest effective daily dose should be used for the shortest duration possible. The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically, especially when treatment continues for more than 4 weeks.</p><p>&nbsp;</p><p>Patients should remain alert for the signs and symptoms of serious arterial thromboembolic events (e.g. chest pain, shortness of breath, weakness, slurring of speech), which can occur without warnings. Patients should be instructed to see a physician immediately in case of such an event.</p><p>&nbsp;</p><p><strong>Haematological effects</strong></p><p>As with other NSAIDs, complete blood counts during long-term treatment with Voltaren gastro-resistant tablets.</p><p>&nbsp;</p><p>Like other NSAIDs, Voltaren gastro-resistant tablets may temporarily inhibit platelet aggregation. Patients with coagulation disorder should be closely monitored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with Voltaren gastro-resistant tablets and/or other pharmaceutical forms of diclofenac.</p><p>&nbsp;</p><p>Observed interactions to be considered</p><p>&nbsp;</p><p>Potent CYP2C9 inhibitors: Caution is recommended when co-prescribing diclofenac with potent CYP2C9&nbsp; inhibitors (such as sulfinpyrazone and voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p><p>&nbsp;</p><p>Lithium: If used concomitantly, diclofenac may raise plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p>&nbsp;</p><p>Digoxin: If used concomitantly, diclofenac may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p>&nbsp;</p><p>Diuretics and antihypertensive agents: Like other NSAIDs, concomitant use of diclofenac with diuretics or antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors) may cause a decrease in their antihypertensive effect. Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy and periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity. (see section 4.4 Special warnings and special precautions for use).</p><p>&nbsp;</p><p>Ciclosporin: Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p>&nbsp;</p><p>Drugs known to cause hyperkalemia: Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>&nbsp;</p><p>Quinolone antibacterials: There have been isolated reports of convulsions which may have been due to concomitant use of quinolones and NSAIDs.</p><p>&nbsp;</p><p>Anticipated interactions to be considered</p><p>&nbsp;</p><p>Other NSAIDs and corticosteroids: Concomitant administration of diclofenac and other systemic NSAIDs or corticosteroids may increase the frequency of gastrointestinal undesirable effects (see section 4.4 Special warnings and special precautions for use).</p><p>&nbsp;</p><p>Anticoagulants and anti-platelet agents: Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4 Special warnings and special precautions for use). Although clinical investigations do not appear to indicate that diclofenac affects the action of anticoagulants, there are isolated reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulants concomitantly. Close monitoring of such patients is therefore recommended.</p><p>&nbsp;</p><p>Selective serotonin reuptake inhibitors (SSRIs): Concomitant administration of systemic NSAIDs and SSRIs may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and special precautions for use).</p><p>&nbsp;</p><p>Antidiabetics: Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect. However, there have been isolated reports of both hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p>&nbsp;</p><p>Methotrexate: Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs are administered less than 24 hours before or after treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increased.</p><p>&nbsp;</p><p>Phenytoin: When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility</p><p>Voltaren gastro-resistant tablets may impair female fertility and is not recommended in women attempting to conceive. Consideration should be given to stopping diclofenac in women who are having difficulty conceiving, or in those being tested for infertility.</p><p>In animals, based on relevant data, impairment of male fertility cannot be ruled out (see section 5.3 &quot;Preclinical data&quot;). The relevance of this finding for humans is unclear.</p><p>&nbsp;</p><p>Pregnancy</p><p>Inhibition of prostaglandin synthesis may have a negative impact on pregnancy and/or embryofetal development. Data from epidemiological studies suggest an elevated risk of miscarriage and of cardiac malformation and gastroschisis following administration of a prostaglandin synthetase inhibitor during early pregnancy. The risk is assumed to rise with the dose and the duration of therapy.</p><p>In animals, administration of a prostaglandin synthetase inhibitor has been shown to result in increased pre-implantation and post-implantation loss and embryofetal lethality. In addition, increased incidences of various malformations, including cardiovascular malformations, have been reported in animals given a prostaglandin synthetase inhibitor during organogenesis (see section 5.3 &quot;Preclinical data&quot;).</p><p>&nbsp;</p><p>During the first and second trimesters of pregnancy, &nbsp;diclofenac should not be given unless absolutely necessaryIf diclofenac is used by a woman attempting to conceive, or during the first or second trimesters of pregnancy, the dose should be kept as low &ndash; and the duration of treatment as short &ndash; as possible.</p><p>&nbsp;</p><p>diclofenac is contraindicated during the third trimester of pregnancy</p><p>All prostaglandin synthetase inhibitors may:</p><p>- expose the fetus to the following risks:</p><p>cardiopulmonary toxicity (with premature closure of the ductus arteriosus, and pulmonary hypertension, also see section 5.3 &quot;Preclinical data&quot;);</p><p>renal dysfunction, which may progress to renal failure with oligohydramnios.</p><p>- expose the mother and child to the following risks:</p><p>possible prolongation of bleeding time, an effect of inhibition of platelet aggregation even at very low doses; inhibition of uterine contractions, resulting in delayed or prolonged labour.</p><p>&nbsp;</p><p>Breast-feeding</p><p>As with other NSAIDs, small amounts of diclofenac passes into the breast milk. . As a precaution, diclofenac should therefore, not be used</p><p>by women who are breast-feeding. If treatment is essential, the infant should be switched to bottle feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients experiencing visual disturbances, dizziness, vertigo, somnolence or other central nervous system disturbances while taking Voltaren gastro-resistant tablets should refrain from driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment. (see section 4.3 and 4.4 for Contraindications and Special warnings and special precautions for use).</p><p>&nbsp;</p><p>Adverse reactions (Table 1) have been reported in clinical trials and/ or spontaneous or literaly sources and are listed according MedDRA &ndash; by system organ class. Within each system organ class , adverse reactions are ranked by frequency. Within each frequency grouping, adverse reactions are listed in order of decreasing seriousness. Adverse reactions (Table 1) are ranked under heading of frequency, the most frequent first, using the following convention: common (&ge; 1/100, &lt; 1/10); uncommon (&ge; 1/1,000, &lt; 1/100); rare (&ge; 1/10,000, &lt; 1/1,000); very rare&nbsp; (&lt; 1/10,000), including isolated reports. The following undesirable effects include those reported with Voltaren gastro-resistant tablets and/or other pharmaceutical forms of diclofenac, with either short-term or long-term use.</p><p>&nbsp;</p><p>The following undesirable effects include those reported with Voltaren gastro-resistant tablets and/or other pharmaceutical forms of diclofenac, with either short-term or long-term use.</p><p>&nbsp;</p><p>Table 1 Adverse drug reactions</p><p>Blood and lymphatic system disorders</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thrombocytopenia, leukopenia, anaemia (including haemolytic and aplastic anaemia), agranulocytosis.</p><p>Immune system disorders</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity,&nbsp;&nbsp; anaphylactic&nbsp;&nbsp; and&nbsp; &nbsp;anaphylactoid&nbsp; &nbsp;reactions (including hypotension and shock).</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angioedema (including face edema).</p><p>Psychiatric disorders</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disorientation,&nbsp;&nbsp; depression,&nbsp;&nbsp; insomnia,&nbsp;&nbsp; nightmare, irritability,</p><p>psychotic disorder.</p><p>Nervous system disorders</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, dizziness.</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Somnolence.</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paraesthesia, memory impairment, convulsion, anxiety,&nbsp; &nbsp;tremor,</p><p>aseptic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; meningitis,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taste&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disturbances&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (dysgeusia), cerebrovascular accident.</p><p>Eye disorders</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Visual impairment, vision blurred, diplopia.</p><p>Ear and labyrinth disorders</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vertigo.</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tinnitus, hearing impaired.</p><p>Cardiac disorders</p><p>Uncommon*:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Myocardial infarction, cardiac failure, palpitations, chest pain.</p><p>Vascular disorders</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertension, vasculitis.</p><p>Respiratory, thoracic and mediastinal disorders</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asthma (including dyspnoea).</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pneumonitis.</p><p>Gastrointestinal disorders</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea,&nbsp;&nbsp; vomiting,&nbsp;&nbsp; diarrhoea,&nbsp;&nbsp; dyspepsia,&nbsp;&nbsp; &nbsp;abdominal&nbsp; &nbsp;pain, flatulence, decreased appetite.</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastritis, gastrointestinal haemorrhage, hematemesis, diarrhoea hemorrhagic, melena, , gastrointestinal ulcer (with or without bleeding or perforation).</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colitis&nbsp; (including&nbsp; haemorrhagic&nbsp; colitis&nbsp; and&nbsp; exacerbation&nbsp;&nbsp; &nbsp;of</p><p>ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis, glossitis, esophageal disorder, intestinal diaphragm disease, pancreatitis.</p><p>Hepatobiliary disorders</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transaminases increased.</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis, jaundice, liver disorder.</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis fulminant, hepatic necrosis, hepatic failure Skin and subcutaneous tissue disorders</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash.</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Urticaria.</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dermatitis&nbsp; bullous,&nbsp; eczema,&nbsp; erythema,&nbsp; erythema&nbsp; &nbsp;multiforme,</p><p>Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&rsquo;s syndrome), dermatitis exfoliative, alopecia, photosensitivity reaction, purpura, Henoch-Schonlein purpura, pruritus.</p><p>Renal and urinary disorders</p><p>&nbsp;</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Renal&nbsp;&nbsp; failure&nbsp;&nbsp; acute,&nbsp;&nbsp; haematuria,&nbsp;&nbsp; proteinuria,&nbsp;&nbsp; nephrotic</p><p>syndrome, tubulointerstitial nephritis, renal papillary necrosis.</p><p>General disorders and administration site conditions Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oedema.</p><p>* The frequency reflects data from long-term treatment with a high dose (150 mg/day).</p><p>&nbsp;</p><p>Description of selected adverse drug reactions Arteriothrombotic events</p><p>Meta-analysis and pharmacoepidemiological data point towards a small increased risk of arteriothrombotic events (for example myocardial infarction) associated with the use of diclofenac, particularly at a high dose (150 mg daily) and during long-term treatment (see section 4.4).</p><p>&nbsp;</p><p>Visual effects</p><p>Visual disturbances such as visual impairment, blurred vision and diplopia appear to be NSAID class effects and are usually reversible on discontinuation. A likely mechanism for the visual disturbances is the inhibition of prostaglandin synthesis and other related compounds that alter the regulation of retinal blood flow resulting in potential changes in vision. If such symptoms occur during diclofenac treatment, an ophthalmological examination may be considered to exclude other causes.</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Food and Drug Authority National Pharmacovigilance Center (NPC):</p><p>&nbsp;</p><p>o Fax: +966112057662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.</p><p>o Toll free phone: 8002490000</p><p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Safety Department Novartis Consulting AG - Saudi Arabia:</p><p>&nbsp;</p><p>o Toll Free Number: 8001240078</p><p>o Phone: +966112658100</p><p>o Fax: +966112658107</p><p>o Email: adverse.events@novartis.com</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Other GCC States:</p><p>-&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>There is no typical clinical picture resulting from diclofenac overdosage. Overdosage can cause symptoms such as vomiting, gastrointestinal haemorrhage, diarrhoea, dizziness, tinnitus or convulsions. In the event of significant poisoning, acute renal failure and liver damage are possible.</p><p>&nbsp;</p><p><strong>Therapeutic measures</strong></p><p>Management of acute poisoning with NSAIDs essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>&nbsp;</p><p>Special measures such as forced diuresis, dialysis, or haemoperfusion are probably of no help in eliminating NSAIDs due to the high protein binding and extensive metabolism.</p><p>&nbsp;</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life-threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>(ATC code: M01A B05).</p><p>&nbsp;</p><p>Mechanism of action</p><p>Voltaren gastro-resistant tablets contains diclofenac sodium, a non-steroidal compound with pronounced antirheumatic, anti-inflammatory, analgesic and antipyretic properties.</p><p>&nbsp;</p><p>Inhibition of prostaglandin biosynthesis, which has been demonstrated experimentally, and is considered fundamental to the mechanism of action of diclofenac . Prostaglandins play a major role in causing inflammation, pain, and fever. in vitro, at concentrations equivalent to those attained in humans. Voltaren does not suppress proteoglycan biosynthesis in cartilage.</p><p><strong>&nbsp;</strong></p><p><strong>Clinical efficacy </strong></p><p>In rheumatic diseases, the anti-inflammatory and analgesic properties of diclofenac elicit a clinical response characterised by improved function and marked relief of signs and symptoms such as pain at rest, pain on movement, morning stiffness and swelling of the joints. In post-traumatic and post-operative inflammatory conditions, Voltaren rapidly relieves both spontaneous pain and pain on movement, and reduces inflammatory swelling and wound oedema.</p><p>In clinical trials, the product has also been shown to exert a pronounced analgesic effect in moderate and severe pain of non-rheumatic origin. It can relieve the pain, and also reduce bleeding, in primary dysmenorrhoea.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Diclofenac is completely absorbed from the gastro-resistant tablets after their passage through the stomach. Although absorption is rapid, its onset may be delayed due to the gastro-resistant coating of the tablet.</p><p>&nbsp;</p><p>Mean peak plasma concentrations of 1.5 micrograms/mL are attained on average 2 hours after ingestion of one tablet of 50 mg.</p><p>&nbsp;</p><p>The tablet pass through the stomach more slowlywhen ingested with or after a meal than when it is ingested before a meal, but the amount of diclofenac absorbed remains the same.</p><p>&nbsp;</p><p>Since about half of diclofenac is metabolized during its first passage through the liver (&quot;first pass&quot; effect), the area under the concentration curve (AUC) following oral or rectal administration is about half that following an equivalent parenteral dose.</p><p>&nbsp;</p><p>Pharmacokinetic behaviour does not change after repeated administration. No accumulation occurs provided the recommended dosage intervals are observed.</p><p>&nbsp;</p><p>The plasma concentrations attained in children given equivalent doses (mg/kg body weight) are similar to those obtained in adults.</p><p>&nbsp;</p><p>Distribution</p><p>Diclofenac is 99.7% bound to serum proteins, mainly to albumin (99.4%). The apparent volume of distribution calculated is 0.12 to 0.17 L/kg.</p><p>&nbsp;</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2 to4 hours after peak plasma values have been reached. The apparent half-life for elimination from the synovial fluid is 3 to 6 hours. Two hours after reaching peak plasma levels, concentrations of the active substance are already higher in the synovial fluid than in the plasma, and they remain higher for up to 12 hours.</p><p>&nbsp;</p><p>&nbsp;A low concentration of Diclofenac (100ng/mL) was detected in the breast milk of one nursing mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose.</p><p>&nbsp;</p><p>Metabolism</p><p>Biotransformation of diclofenac is partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites (3&#39;-hydroxy-,4&#39;-hydroxy-,5- hydroxy-,4&#39;,5-dihydroxy- and 3&#39;-hydroxy-4&#39;-methoxy-diclofenac), most of which are subsequently converted to glucuronide conjugates. Two of these phenolic metabolites are biologically active, but to a much smaller extent than diclofenac itself.</p><p>&nbsp;</p><p>Elimination</p><p>Total systemic clearance of diclofenac from plasma is 263 &plusmn;56 mL/min (mean value &plusmn;SD). The terminal half-life is 1 to 2 hours. Four of the metabolites, including the two that are active, also have short plasma half-lives of 1 to 3 hours. the virtually inactive. metabolite, 3&#39;-hydroxy-4&#39;-methoxy-diclofenac has a much longer plasma half-life.</p><p>&nbsp;</p><p>About 60% of the dose is excreted in the urine as metabolites, Compared with Less than 1% as unchanged substance. The rest of the dose is eliminated as metabolites via the bile in the faeces.</p><p>&nbsp;</p><p>Linearity/ Non - linearity</p><p>The amount absorbed is in linear proportion to the size of the dose.</p><p>&nbsp;</p><p>Pharmacokinetics in Special populations</p><p>No relevant age-dependent differences in the drug&rsquo;s absorption, metabolism, or excretion have been observed.</p><p><em>In patients with renal impairment, the drug&rsquo;s single-dose pharmacokinetics do not suggest any accumulation of unchanged active substance with the usual dosage schedule. In patients with a creatinine clearance of &lt; </em>&nbsp;10mL/min, theoretical steady-state plasma levels of the metabolites are about 4 times higher than in normal subjects. However, the metabolites are ultimately cleared through the bile.</p><p>&nbsp;</p><p>In patients with hepatic impairment (chronic hepatitis or compensated cirrhosis), the pharmacokinetics and metabolism of diclofenac are the same as in patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data from safety pharmacology studies, acute and repeated dose toxicity studies and genotoxicity, mutagenicity and carcinogenicity studies with diclofenac revealed no evidence of a specific hazard for humans at the intended therapeutic doses.</p><p>The increased incidence of lymphomas (thymus) in mice, and subcutaneous fibromas, fibroadenomas (mammary gland) or C-cell adenomas (thyroid gland) in rats were all within the historical control range of the laboratory for the animal strain used, and are considered to have occurred by chance.</p><p>In all toxicity studies&nbsp;carried out in rats, hypertrophy of mesenteric lymph nodes or lymphadenitis with reactive hyperplasia were observed. These changes were accompanied by neutrophilia that was also observed in studies in monkeys. These are presumably secondary reactions to the ulcers observed in the gastrointestinal tract. In a two-year study, a dose-dependent increase in thrombotic vascular occlusions in the heart was observed in rats treated with diclofenac.</p><p>Additional studies indicate that, with repeated oral doses in rats (&gt; 1 mg/kg body weight), diclofenac causes effects that influence fertility (lower testosterone level, and decreased epididymal and testicular weight in association with histopathological changes). Similar effects were also observed in the F1 generation following doses of &ge; 1.25 mg/kg in a two-generation study. In dogs, daily subcutaneous doses of 2 mg/kg diclofenac sodium led to an increased spermatid count. Further studies describe a decreased mating frequency in female rats following a repeated dose of &ge; 0.5 mg/kg diclofenac. For this reason, an influence on both male and female fertility cannot be ruled out.</p><p>Diclofenac crosses the placental barrier in rodents. Administration of NSAIDs (including diclofenac) inhibited ovulation in rabbits and implantation and placentation in rats, and led to premature closure of the ductus arteriosus in pregnant rats. Maternally toxic doses of diclofenac were associated with dystocia, prolonged gestation, decreased fetal survival, and intrauterine growth retardation in rats. The slight effects of diclofenac on reproduction parameters and delivery as well as closure of the ductus arteriosus <em>in utero</em> are pharmacological effects of this class of prostaglandin synthetase inhibitors (see sections &quot;4.3 Contraindications&quot; and &quot; 4.6 Fertility, Pregnancy and lactation&quot;).</p><p>In a study in mice, teratogenicity (cleft palate) was observed at the maternally toxic dose of 4 mg/kg. In rats and rabbits, doses up to the maternally toxic level did not lead to teratogenic effects. Delayed ossification and reduced fetal weight in a study in rabbits were the only changes observed in these investigations.</p><p>At maternally toxic doses, the perinatal and post-natal development of the offspring were impaired (fertility, see above, also birth weight and delayed post-natal growth).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Core for 50 mg: Cellulose microcrystalline; lactose monohydrate; magnesium stearate; maize starch; povidone; silica, colloidal anhydrous; sodium starch glycolate (type A);</p><p>&nbsp;</p><p>Coating for 50 mg: hypromellose; iron oxide red (E172); iron oxide yellow (E172); macrogoglycerol hydroxystearate; Methacrylic acid &ndash; ethyl acrylate copolymer; macrogol 8000; talc; titanium dioxide (E171); Simeticone; alpha-octadecyl-omega-hydroxy-polyglykolether; sorbic acid.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Do not store above 30&deg;C.</li><li>Store in the original package</li><li>Voltaren gastro-resistant tablets must be kept out of the reach and sight of children.</li><li>protect from moisture&nbsp;</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong>50 mg gastro-resistant tablets x 20</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG. 
www.Novartis.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                04/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>